DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$6.56
+0.54%
Mkt Cap $341.62M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+27.1%
Consensus $8.33 vs current $6.56
NASDAQ·Healthcare·Biotechnology
$6.56
+0.54%
Mkt Cap $341.62M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+27.1%
Consensus $8.33 vs current $6.56